Sam Samad Quest Diagnostics Inc (DGX) insider trading activity

Sam Samad is Executive Vice President & CFO of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 21,356 shares of DGX, which is worth approximately $2.93 Million. The most recent transaction as insider was on Apr 22, 2024, when has been sold 24 shares (Common Stock) at a price of $126.25 per share, resulting in proceeds of $3,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.4K

0.11% 3M change

4.77% 12M change

Total Value Held $2.93 Million

SAM SAMAD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 22 2024	BUY Grant, award, or other acquisition	$3,030 $126.25 p/Share	24 Added 0.11%	21,356 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$82,892 $126.36 p/Share	656 Reduced 2.98%	21,332 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	5,478 Added 19.94%	21,988 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	$2,198 $129.33 p/Share	17 Added 0.1%	16,510 Common Stock
Oct 23 2023	BUY Grant, award, or other acquisition	$2,211 $122.86 p/Share	18 Added 0.11%	16,493 Common Stock
Jul 14 2023	SELL Payment of exercise price or tax liability	$547,963 $140.18 p/Share	3,909 Reduced 19.18%	16,475 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	4,710 Added 18.77%	20,384 Common Stock

Also insider at

ILMN

ILLUMINA, INC. Healthcare

SVP and CFO

IDXX

IDEXX LABORATORIES INC Healthcare

Director

Sam Samad

Executive Vice President & CFO

Westbrook, ME

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account